RWM
LEGN icon

Raffa Wealth Management’s Legend Biotech LEGN Stock Holding History

Raffa Wealth Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462 Hold
16
– – ﹤0.01% 1194
2026
Q1 		$289 Hold
16
– – ﹤0.01% 1127
2025
Q4 		$348 Hold
16
– – ﹤0.01% 1102
2025
Q3 		$522 Hold
16
– – ﹤0.01% 1061
2025
Q2 		$568 Hold
16
– – ﹤0.01% 975
2025
Q1 		$543 Hold
16
– – ﹤0.01% 944
2024
Q4 		$521 Hold
16
– – ﹤0.01% 999
2024
Q3 		$780 Hold
16
– – ﹤0.01% 904
2024
Q2 		$709 Buy
+16
New +$738 ﹤0.01% 986

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raffa Wealth Management's LEGN Position: Q2 2026 in Review

Raffa Wealth Management held its Legend Biotech (LEGN) position steady in Q2 2026 at 16 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Raffa Wealth Management first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $780 in Q3 2024. 201 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Raffa Wealth Management held 16 shares of Legend Biotech worth $462 as of Q2 2026.
  • Raffa Wealth Management left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1194 holding.
  • Raffa Wealth Management first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
  • Raffa Wealth Management's Legend Biotech position peaked at $780 in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.